Page last updated: 2024-08-24

cidofovir anhydrous and Vaccinia

cidofovir anhydrous has been researched along with Vaccinia in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.78)	18.2507
2000's	25 (69.44)	29.6817
2010's	10 (27.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Keith, KA; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN	1
Andrei, G; Balzarini, J; Hocková, D; Holý, A; Snoeck, R	1
Guan, H; Nuth, M; Ricciardi, RP; Saw, YL; Zhukovskaya, N	1
Costa, GB; de Assis, FL; de Oliveira, DB; Kroon, EG; Mota, BEF; Pires, MA; Rodrigues, NFS	1
Dagley, A; Downs, B; Hagloch, J; Smee, DF; Tarbet, EB	1
Foster, SA; Godin, SJ; Keilholz, L; Khouri, J; Long, J; Rose, ML; Trost, LC	1
Damaso, CR; Jesus, DM; Moussatché, N	1
Chen, ZW; Fortman, J; Huang, D; Shao, L; Wang, R; Wei, H	1
Hurst, BL; Smee, DF; Wong, MH	1
Bray, M; Fisher, RW; Kennedy, MC; Mikolajczyk, MG; Reed, JL; Scott, DE; Snoy, PJ	1
Bailey, KW; Smee, DF; Tarbet, EB; Wong, MH	1
Ennis, J; Russell, A; Smee, DF; Turner, JD; Wong, MH	1
Didier, PJ; Doyle, LA; Killeen, SZ; Marx, PA; Reddy, JD; Roy, CJ; Sivasubramani, SK; Talton, JD; Verreault, D	1
Enserink, M	1
De Clercq, E; Neyts, J	2
Bell, DM; Casey, CG; Cono, J	1
Bray, M; Wright, ME	1
Bailey, KW; Sidwell, RW; Smee, DF	2
Collins, DJ; Kern, ER; Quenelle, DC	2
Beadle, JR; Collins, DJ; Hostetler, KY; Kern, ER; Quenelle, DC; Wan, WB	1
Bailey, KW; Beadle, JR; Hostetler, KY; Sidwell, RW; Smee, DF; Wong, MH	1
De Clercq, E; Leyssen, P; Neyts, J; Verbeken, E	1
Bailey, KW; Sidwell, RW; Smee, DF; Wandersee, MK; Wong, MH	1
Bailey, KW; Holy, A; Hostetler, KY; Sidwell, RW; Smee, DF; Wandersee, MK	1
Andrei, G; Balzarini, J; De Clercq, E; Hocková, D; Holý, A; Leyssen, P; Naesens, L; Neyts, J; Pannecouque, C; Snoeck, R; Ying, C	1
Allen, SD; Knorr, CW; Smee, DF; Torres, AR	1
Evans, DH; Hostetler, KY; Kornbluth, RS; Sidwell, RW; Smee, DF; Snarsky, V	1
Aldern, KA; Beadle, JR; Hartline, CB; Hostetler, KY; Keith, KA; Kern, ER; Ruiz, JC	1
Glazer, RI; Hurst, BL; Rahman, A; Sidwell, RW; Smee, DF; Wong, MH	1
Adams, MM; Moyer, RW; Rice, AD	1
Becker, MN; Keith, KA; Kern, ER; Luo, M; Moyer, RW; Obraztsova, M; Prichard, MN; Quenelle, DC	1
Gilray, JA; Mercer, AA; Nettleton, PF; Reid, HW	1
Bailey, KW; Sidwell, RW; Smee, DF; Wong, MH	1

Reviews

2 review(s) available for cidofovir anhydrous and Vaccinia

Article	Year
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives. Antiviral research, 2003, Volume: 57, Issue:1-2 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; History, 20th Century; Humans; Organophosphonates; Organophosphorus Compounds; Poxviridae Infections; Smallpox; Time Factors; Vaccinia	2003
Progressive vaccinia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Mar-15, Volume: 36, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Methisazone; Organophosphonates; Organophosphorus Compounds; Ribavirin; Vaccination; Vaccinia	2003

Other Studies

34 other study(ies) available for cidofovir anhydrous and Vaccinia

Article	Year
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Animals; Antiviral Agents; beta-Galactosidase; Cell Line; Cell Proliferation; Cell Survival; Cowpox; Cytopathogenic Effect, Viral; DNA, Viral; Drug Resistance, Viral; Humans; Mice; Mice, Inbred BALB C; Nucleosides; Orthopoxvirus; Poxviridae Infections; Structure-Activity Relationship; Vaccinia	2009
Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: efficient synthesis and antiviral activity. Bioorganic & medicinal chemistry, 2011, Aug-01, Volume: 19, Issue:15 Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Herpes Simplex; HIV; HIV Infections; Humans; Mice; Nucleosides; Organophosphonates; Simplexvirus; Structure-Activity Relationship; Vaccinia; Vaccinia virus; Virus Diseases; Viruses	2011
Design of potent poxvirus inhibitors of the heterodimeric processivity factor required for viral replication. Journal of medicinal chemistry, 2013, Apr-25, Volume: 56, Issue:8 Topics: Antiviral Agents; DNA, Viral; Drug Design; Humans; Indoles; Inhibitory Concentration 50; Structure-Activity Relationship; Vaccinia; Vaccinia virus; Viral Proteins; Virus Replication	2013
In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades. Antiviral research, 2018, Volume: 152 Topics: Antiviral Agents; Benzamides; Brazil; Cidofovir; Humans; Isoindoles; Phylogeny; Vaccinia; Vaccinia virus	2018
Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins; Infusions, Parenteral; Mice, Hairless; Mice, SCID; Organophosphonates; Skin Diseases, Infectious; Treatment Outcome; Vaccinia	2015
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease. Antiviral research, 2015, Volume: 117 Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Injections, Intradermal; Organophosphonates; Rabbits; Random Allocation; Smallpox; Vaccinia; Vaccinia virus; Variola virus	2015
In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC. International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Animals; Antiviral Agents; Brazil; Cattle; Cattle Diseases; Cell Line; Chlorocebus aethiops; Cidofovir; Communicable Diseases, Emerging; Cytosine; Disease Outbreaks; Humans; Kidney; Microbial Sensitivity Tests; Organophosphonates; Smallpox Vaccine; Vaccinia; Vaccinia virus; Virus Replication; Zoonoses	2009
Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox. Journal of virology, 2009, Volume: 83, Issue:2 Topics: Animals; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Drug Incompatibility; Macaca fascicularis; Mpox (monkeypox); Organophosphonates; Smallpox Vaccine; T-Lymphocytes; Vaccinia	2009
Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice. Antiviral chemistry & chemotherapy, 2010, Apr-14, Volume: 20, Issue:5 Topics: Animals; Antiviral Agents; Aurintricarboxylic Acid; Cell Line; Cidofovir; Cytosine; Ethacrynic Acid; Mice; Mice, Inbred BALB C; Organophosphonates; Respiratory Tract Infections; Time Factors; Vaccinia; Vaccinia virus	2010
Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin. Clinical and vaccine immunology : CVI, 2011, Volume: 18, Issue:1 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Therapy, Combination; HeLa Cells; Humans; Immunoglobulins; Mice; Mice, SCID; Organophosphonates; Post-Exposure Prophylaxis; Skin; Survival Rate; Vaccination; Vaccinia; Vaccinia virus; Vero Cells	2011
Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances. Antiviral chemistry & chemotherapy, 2011, May-12, Volume: 21, Issue:5 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cyclophosphamide; Cytosine; Female; Immune Tolerance; Immunosuppression Therapy; Mice; Mice, Hairless; Microbial Sensitivity Tests; Organophosphonates; Purines; Skin Diseases, Viral; Vaccinia; Vaccinia virus	2011
Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201). PloS one, 2011, Volume: 6, Issue:10 Topics: Adenoviridae; Administration, Intranasal; Animals; Body Weight; Cidofovir; Cytosine; Female; Genetic Vectors; Interferon-alpha; Mice; Mice, Inbred BALB C; Organophosphonates; Protective Agents; Respiratory Tract Infections; Survival Analysis; Time Factors; Vaccinia; Vaccinia virus	2011
Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model. Antiviral research, 2012, Volume: 93, Issue:1 Topics: Administration, Inhalation; Animals; Antiviral Agents; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Lung; Male; Organophosphonates; Post-Exposure Prophylaxis; Rabbits; Vaccinia; Vaccinia virus	2012
Public health. Treating vaccine reactions: two lifelines, but no guarantees. Science (New York, N.Y.), 2002, Dec-20, Volume: 298, Issue:5602 Topics: Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytosine; Encephalomyelitis, Acute Disseminated; Humans; Immunization, Passive; Immunoglobulins; Kaposi Varicelliform Eruption; Mice; Organophosphonates; Organophosphorus Compounds; Risk Factors; Smallpox Vaccine; Vaccinia; Vaccinia virus	2002
Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2003, Feb-21, Volume: 52, Issue:RR-4 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antiviral Agents; Central Nervous System Diseases; Child; Child, Preschool; Cidofovir; Contraindications; Cross Infection; Cytosine; Disease Transmission, Infectious; Drugs, Investigational; Eye Infections; Female; Fetal Diseases; Humans; Hypersensitivity; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Tests; Infant; Infection Control; Infectious Disease Transmission, Vertical; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pregnancy; Risk Factors; Skin Diseases, Eczematous; Skin Diseases, Vesiculobullous; Smallpox Vaccine; Vaccination; Vaccinia	2003
Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice. Chemotherapy, 2003, Volume: 49, Issue:3 Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox; Cytosine; Female; Infusions, Parenteral; Liver; Lung Diseases; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Vaccinia	2003
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Viral; Female; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vero Cells	2003
Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2 Topics: Administration, Oral; Animals; Anti-HIV Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Ethers; Female; Lipids; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vaccinia virus; Viral Load; Virus Replication	2004
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. International journal of antimicrobial agents, 2004, Volume: 23, Issue:5 Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Heart; Liver; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Oxygen; Purines; Respiratory Tract Infections; Ribavirin; Salivary Glands; Spleen; Treatment Outcome; Vaccinia; Vaccinia virus; Viral Plaque Assay; Viremia	2004
Efficacy of cidofovir in a murine model of disseminated progressive vaccinia. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Mice; Mice, Nude; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vaccinia; Vaccinia virus	2004
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Antiviral research, 2004, Volume: 63, Issue:1 Topics: Administration, Cutaneous; Animals; Antiviral Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Mice; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Vaccinia; Vaccinia virus	2004
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. The Journal of infectious diseases, 2004, Sep-15, Volume: 190, Issue:6 Topics: Administration, Topical; Animals; Antiviral Agents; Brain; Cidofovir; Cyclophosphamide; Cytosine; Disease Models, Animal; Female; Immunocompromised Host; Immunosuppressive Agents; Injections, Intraperitoneal; Kidney; Liver; Lung; Mice; Mice, Hairless; Organophosphonates; Organophosphorus Compounds; Skin; Specific Pathogen-Free Organisms; Spleen; Survival Analysis; Time Factors; Vaccinia; Viral Plaque Assay	2004
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice. Antiviral chemistry & chemotherapy, 2005, Volume: 16, Issue:3 Topics: Animals; Cells, Cultured; Cidofovir; Cytosine; Disease Models, Animal; Drug Resistance; Mice; Mice, Inbred BALB C; Mice, SCID; Mutation; Organophosphonates; Vaccinia; Vaccinia virus; Virus Replication	2005
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7 Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofovir; Cytosine; HIV Infections; Humans; Mice; Mice, Nude; Models, Chemical; Moloney murine sarcoma virus; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Poxviridae; Poxviridae Infections; Purines; Pyrimidines; Vaccinia; Vaccinia virus	2005
Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. Antiviral research, 2006, Volume: 72, Issue:2 Topics: Animals; Antiviral Agents; Cidofovir; Cowpox; Cytokines; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Vaccinia; Vaccinia virus	2006
Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Administration, Intranasal; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genes, Viral; Mice; Mice, Inbred BALB C; Mutation; Organophosphonates; Phenotype; Specific Pathogen-Free Organisms; Vaccinia; Vaccinia virus; Vero Cells	2006
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir. Antiviral research, 2007, Volume: 75, Issue:1 Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cowpox; Cytomegalovirus Infections; Cytosine; Herpes Simplex; HIV-1; Humans; In Vitro Techniques; Molecular Structure; Organophosphonates; Sensitivity and Specificity; Vaccinia	2007
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. Antiviral research, 2007, Volume: 76, Issue:2 Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Injections, Intraperitoneal; Mice; Organophosphonates; Survival Analysis; Thymidine; Vaccinia; Vaccinia virus; Viral Plaque Assay	2007
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox. Journal of virology, 2007, Volume: 81, Issue:20 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Organophosphonates; Poxviridae Infections; Rabbits; Smallpox; Survival Rate; Vaccinia; Vaccinia virus; Viremia	2007
Isolation and characterization of cidofovir resistant vaccinia viruses. Virology journal, 2008, May-14, Volume: 5 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Humans; Mice; Models, Molecular; Mutation; Organophosphonates; Vaccinia; Vaccinia virus; Vero Cells; Viral Plaque Assay; Virulence	2008
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Journal of medical virology, 1993, Volume: 41, Issue:3 Topics: Animals; Antiviral Agents; Brain; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney; Liver; Lung; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vaccinia virus; Virus Replication	1993
Parapoxviruses are strongly inhibited in vitro by cidofovir. Antiviral research, 2000, Volume: 48, Issue:3 Topics: Animals; Antiviral Agents; Cell Line; Cidofovir; Cytosine; Organophosphonates; Organophosphorus Compounds; Parapoxvirus; Poxviridae Infections; Sheep; Vaccinia; Vaccinia virus; Virus Replication	2000
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1 Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox virus; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Nose; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Paranasal Sinuses; Pneumonia, Viral; Spleen; Vaccinia; Vaccinia virus; Viral Load; Viremia	2001
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral research, 2001, Volume: 52, Issue:1 Topics: Administration, Intranasal; Animals; Antiviral Agents; Blood Gas Monitoring, Transcutaneous; Body Weight; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Injections, Intraperitoneal; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Respiratory System; Respiratory Tract Infections; Time Factors; Vaccinia; Vaccinia virus; Vero Cells; Viral Plaque Assay; Virus Replication	2001